In Malaysia, updates to registered drugs are managed by the National Pharmaceutical Regulatory Agency (NPRA). Manufacturers must submit variation applications detailing changes. The NPRA evaluates these for safety, efficacy, and quality. Approved updates are reflected in the product registration, ensuring compliance with regulatory standards and maintaining public health safety.